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Maxillofacial Pathology, Government Dental College and Hospital, Hyderabad, Telangana. A total of 40 cases which were clinically and histopathologically diagnosed as NOM (n = 10) and OSCC (n = 30; WDOSCC=10, MDOSCC=10, PDOSCC=10) were stained for MUC1 mucin.
Exclusion CriteriaThe following criteria were excluded from the study:1. Patients with previous history of malignancy.2. Patients undergoing treatment for malignancy (surgery, chemotherapy, and radiotherapy) and,3. Patients with metastatic tumors in jaws from systemic malignancies.The percentages of positive cells are evaluated. An additional tissue section was taken from all the cases and stained with hematoxylin and eosin for comparative purpose.
Immunohistochemistry3 um thick sections were extracted from selected tissue blocks and loaded on to silane-coated slides. Following deparaffinization by heating on a slide warmer for 1 h at 60°C and treatment with xylene, sections were rehydrated in ethanol and water. Then, sections were placed in a commercial microwave antigen retrieval system (EZ Retrieval System, Pathnsitu Biotechnologies Pvt., Ltd) containing tris (hydroxymethyl) aminomethane ethylene-diamine-tetraacetic acid buffer and treated at 95°C for five cycles: 5 min for 
INTRODUCTIONA pressing problem in the world is oral cancer, and the WHO predicts a worldwide continuous increase in the number of oral cancer patients. Regardless of the easy access of oral cavity for clinical examination, oral squamous cell carcinoma (OSCC) is routinely diagnosed in advanced stages. Most common reasons are the initial wrong diagnosis and the ignorance from the patient or from attending physician. Early detection of disease progression remains a challenging task mainly due to lack of a reliable molecular marker that predicts both early diagnosis and prognosis of this devastating disease.[1,2]Mucins are glycoproteins with high molecular weight that plays a vital role in cell growth, differentiation, and cell signaling. MUC1 mucin is a membrane-bound mucin encoded by the MUC1 gene.[2,3] MUC-1 promotes neoplastic transformation, tumor survival, angiogenesis, and metastasis.[4]The present study was conducted to evaluate, compare, and correlate the expression of MUC1 mucin protein and its significance in normal oral mucosa (NOM) and OSCC by Immunohistochemical method.
MATERIALS AND METHODSThe present study was conducted on the paraffin-embedded blocks retrieved from the archives of the Department of Oral and 
ABSTRACT
Background: MUC1 mucin is a membrane-bound mucin encoded by the MUC1 gene. Alteration in glycosylation of mucins is 
associated with the development and progression of malignancy. Therefore, mucins are used as markers which are valuable to 
distinguish normal and diseased conditions. Although expression of MUC1 has been identified in a various neoplasms, only few 
studies have done to estimate MUC1 expression in oral carcinomas.  Aims and Objectives: The aim of this study is to evaluate, 
compare, and correlate the MUC-1 immunoexpression and its significance in normal oral mucosa (NOM) and in different grades 
of oral squamous cell carcinoma (OSCC).  Materials and Methods: Our study included 30 histopathologically diagnosed tissue 
sections of different grades of OSCC, which were immunostained for MUC1 mucin expression and 10 cases of NOM as controls. 
The percentage of the positivity of cells and staining intensity was analyzed according to the immunoreactive scoring system and 
statistically analyzed by Pearson’s Chi-Square test. Membranous and cytoplasmic staining was considered as positive for MUC1 
mucin immunoexpression.  Results: There was statistically significant difference in the percentage of positivity of cells and 
staining intensity from NOM to OSCC and also in different grades of OSCC with a P < 0.001.  Conclusion: The findings of our 
study suggest that MUC 1 plays an important role in pathogenesis and can be regarded as a valuable marker for OSCC.
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first cycle and 3 min each for remaining cycles for antigen retrieval. Antigen-retrieved sections were allowed to cool for 30 min and then rinsed in distilled water followed by washing in TRIS buffer. Further slides were treated with 3% hydrogen peroxide for 5 min to block endogenous peroxidase activity. Then, tissue sections were incubated with a prediluted primary antibody against MUC1 (Rabbit Monoclonal, Clone EP 85, Pathnsitu Biotechnologies Pvt., Ltd.) for 30 min at room temperature. Then, tissue sections were incubated with horseradish peroxidase one-step polymer - secondary antibody. Immunoreactions for MUC1 were visualized with diaminobenzidine chromogen. Finally, sections were counterstained with Harris hematoxylin, dehyrated in ethanol and xylene, and finally mounted with dibutyl phthalate xylene.
Interpretation of the SlidesThe staining pattern in colon carcinoma was used as the positive control. The distribution of positive cells was first examined under low magnification (×10); among which, 5 fields are randomly selected to calculate the percentage of positive cells under high magnification (×40) and we also observed staining intensity of MUC1 and grading was done according to the immunoreactive score (IRS) given by Remmele and Stegner as shown in the Table 1.[5] Membranous and cytoplasmic staining was considered as positive for MUC1 mucin immunoexpression. All IHC-stained slides together with the corresponding H and E sections were analyzed by two observers.
Statistical AnalysisThe obtained data were subjected to SPSS software version 20.0. Pearson’s Chi-square test was computed to calculate the association between the type of condition and percentage of positivity of cells.
RESULTSAnalysis revealed that majority of the samples in control group showed no positive cells. However, well-differentiated squamous cell carcinoma, moderately differentiated squamous cell carcinoma, and poorly differentiated squamous cell carcinoma (PDSCC) groups showed that majority of the samples showed 51–80% and >80% positivity of cells. There was a shift in the percentage positivity of cells from controls to OSCC groups. This association of greater percentage of positivity of cells with squamous cell carcinoma samples and association of no positive cells with NOM were found to be statistically significant with a 
P < 0.01 [Table 2 and Graph 1].There was also statistically significant difference in the intensity of staining in NOM and different grades of OSCC with P< 0.01 [Table 3 and Graph 2].When IRS score was compared, there was statistically significant difference between NOM and different grades of OSCC (P < 0.01) [Table 4 and Graph 3].
Table 1: IRS
A (percentage of positive cells) B (intensity of staining) IRS score (multiplication of A and B)
0 = no positive cells 0 = no color reaction 0–1 = negative
1≤10% of positive cells 1 = mild reaction 2–3 = mild
2 = 10–50% positive cells 2 = moderate reaction 4–8 = moderate
3 = 51–80% positive cells 3 = intense reaction 9–12 = strongly positive
4≥80% positive cells Final IRS score (A × B): 0–12
IRS: Immunoreactive score
Table 2: Percentage of positive cells in different groups
Group Positive cells Total P value
No positive 
cells
<10% positive 
cells
10–50% positive 
cells
51–80% positive 
cells
>80% positive 
cells
NOM 8 (80.0) 1 (10.0) 1 (10.0) 0 (0.0) 0 (0.0) 10 (100.0) Χ2 = 63.375 P<0.01
WDSCC 0 (0.0) 0 (0.0) 4 (40.0) 4 (40.0) 2 (20.0) 10 (100.0)
MDSCC 0 (0.0) 0 (0.0) 1 (10.0) 6 (60.0) 3 (30.0) 10 (100.0)
PDSCC 0 (0.0) 0 (0.0) 1 (10.0) 4 (40.0) 5 (50.0) 10 (100.0)
Total 9 (18.0) 3 (6.0) 11 (22.0) 16 (32.0) 11 (22.0) 50 (100.0)
NOM: Normal oral mucosa, WDSCC: Well-differentiated squamous cell carcinoma, MDSCC: moderately differentiated squamous cell carcinoma, PDSCC: Poorly differentiated 
squamous cell carcinoma
Table 3: Staining intensity among different groups
Group Intensity of staining Total Chi-square
Negative Mild staining Moderate staining
NOM 8 (80.0) 2 (20.0) 0 (0.0) 10 (100.0) Χ2=35.667 P<0.01
WDSCC 0 (0.0) 4 (40.0) 6 (60.0) 10 (100.0)
MDSCC 0 (0.0) 5 (50.0) 5 (50.0) 10 (100.0)
PDSCC 1 (10.0) 6 (60.0) 3 (30.0) 10 (100.0)
Total 10 (20.0) 25 (50.0) 15 (30.0) 50 (100.0)
NOM: Normal oral mucosa, WDSCC: Well-differentiated squamous cell carcinoma, MDSCC: Moderately differentiated squamous cell carcinoma, PDSCC: Poorly differentiated 
squamous cell carcinoma
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DISCUSSIONThe second most leading cause of mortality in economically developed countries (next to heart diseases) and the third most leading cause of death in developing countries (next to heart diseases and diarrheal diseases) are cancer.[6] Among all cancers, oral cancer is the most prevalent in the world, and it ranks third among cancers in South and Central Asia. In males, it is the most common cancer, while in females, it is third most common cancer in India.OSCC constitutes 95%–98% of all oral cancers.[6] It is the most common cancer accounting for 12% of all cancers in men and 8% of all cancers in women.[3] In India, one of the major factors which worsen the disease prognosis is late diagnosis of carcinoma.[7] It is known for its detrimental and lethal effect.[8] The survival rates of OSCC were 59.9% in 1 year, 40.7% in 2 years, and 27.8% in 5 years.[9]
Knockdown and overexpression studies of MUC1 discovered that it leads to increased anti-adhesive properties and tumorigenicity in number of systems. Under in vitro conditions, by mediating binding to some molecular ligands and blocking binding with other ligands, overexpression of MUC1 has been shown to reduce adhesion between neighboring cells and between cells and extracellular matrix.[10]Mucins are multifunctional glycoproteins that are thought to exclusively represent the principal component of mucus, which help in protecting and lubricating epithelial surfaces within the human body. In addition, mucins are also involved in signaling pathways that direct coordinated cellular responses such as secretion of specialized cellular products, cell proliferation, differentiation, and apoptosis.[11]It is accepted generally that the structure and distribution of cell surface glycoconjugates change during malignant transformation and tumor progression. The findings of the present study suggest that MUC1 mucin may be a useful indicator of malignant potential given its increased rate of expression during disease progression to OSCC. This MUC1 upregulation may reflect early cellular changes from normal cell-cell and cell-matrix interaction toward bizarre, pathophysiologic, heterotypic cell surface adhesion properties. Expression of MUC1 mucin may be associated to the invasion or metastasis of carcinoma cells.[9-11]Cancer cells express aberrant forms or amounts of mucins. These aberrant forms arise as a result of the deregulation of mucin core proteins and the enzymes that modify them, during the transformation of tumor cells.[3,12]Mucins are used by cancer cells for protection from adverse growth conditions and to control the local molecular microenvironment during invasion and metastasis.[11]
Graph 1: Percentage of positive cells in different groups
Graph 2: Staining intensity among different groups
Graph 3: Immunoreactive score grading in different groups
Table 4: Association of type of lesion with IRS grading
Group IRS score Total Chi-square
Negative 
expression
Positive, weak 
expression
Positive, intermediate 
expression
NOM 8 (80.0) 2 (20.0) 0 (0.0) 10 (100.0) Χ2=33.208 P<0.01
WDSCC 0 (0.0) 4 (40.0) 6 (60.0) 10 (100.0)
MDSCC 0 (0.0) 5 (50.0) 5 (50.0) 10 (100.0)
PDSCC 1 (10.0) 6 (60.0) 3 (30.0) 10 (100.0)
Total 10 (20.0) 24 (48.0) 16 (32.0) 50 (100.0)
NOM: Normal oral mucosa, WDSCC: Well-differentiated squamous cell carcinoma, MDSCC: Moderately differentiated squamous cell carcinoma, PDSCC: Poorly differentiated 
squamous cell carcinoma
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It is well established that, in several neoplasms, membrane-associated mucin MUC1 is aberrantly glycosylated and overexpressed. The cytoplasmic tail of MUC1 can bind and signal through beta-catenin and the mitogen-activated protein kinase. The early studies showed that MUC1 was phosphorylated on both serine and tyrosine residues within the cytoplasmic tail and also changes in phosphorylation of cytoplasmic MUC1 correlate with differences in cell adhesion.[10]Many studies have indicated that MUC1 mucin can act as an antiadhesion molecule.[11] Overexpression of MUC1 mucin on the cell surface reduces cell-cell and cell-extracellular matrix adhesion, perhaps the large, elongated, and rigid structure of MUC1 mucin interferes with interactions between adhesion molecules and their ligands.[13] Cells that express abundant MUC1 mucin have decelerated levels of interaction between integrins and the extracellular matrix.[14] MUC1 mucin overexpression was associated with invasive and metastatic tumors of the pancreas, gallbladder, colon, and oral epithelium.[11] In cancer cells, increased expression of MUC1 promotes invasion of cancer cell through beta-catenin, resulting in the initiation of epithelial-mesenchymal transition which promote the formation of metastasis.[15,16]In the present study, cases of different grades of OSCC and well-differentiated OSCC showed membranous and cytoplasmic 
staining positive staining, also in keratin pearls [Figure 1], which is in accordance with Kumar et al. In moderately differentiated OSCC, membranous moderate staining was observed [Figure 2], while in poorly differentiated OSCC, only membranous staining was observed [Figure 3]. There is an overexpression of MUC1 in OSCC compared with its normal and counterpart, as seen in a study conducted by Kumar et al.,[3] Nitta et al.,[13] Narashiman 
et al.,[17] and Kaur et al.[10]The association of greater percentage positivity of cells with OSCC samples than NOM was found to be statistically significant with P < 0.01. This might be because the cancer cells utilize mucins for cell proliferation. The association of more staining with OSCC samples in comparison with NOM was found to be significant statistically with P < 0.01. This might be because the cancer cells use mucins for their survival, protection from innate immunity, and invasion which are the characteristic feature of malignancy.[10-12]There is a progressive increase of positive expression from NOM to OSCC which was found statistically significant with a P < 0.01, as IRS values are based on the percentage of positivity and staining intensity. The histological grades of OSCC were also compared, and we found a significant decrease in the immunoexpression of MUC1 from well-differentiated to poorly differentiated OSCC through moderately differentiated OSCC, as seen in Narashiman 
et al.,[17] Weed et al.,[18] and Guillem et al.[19] This is attributed to the inability of the less differentiated squamous cells to express mucins compared with that of well-differentiated cells of OSCC. This may be comparable to an unexplained complex immunoreactive phenomenon. Probably this might be due to the fact that the decelerated catabolism of certain inhibitory proteins for MUC1 immunoexpression in well-differentiated mature atypical cells. In PDSCC, there might be increased synthesis of certain intrinsic inhibitory proteins for MUC1 for some unknown mechanism which altered maturation and de-differentiated of cancer cells.[17-19]In general, MUC1 is well expressed in the well-keratinized areas which are usually seen in well-differentiated OSCC. Tumor cells produce MUC1 mucin which is released into the circulation and captured by IgG antibodies forming MUC1-IgG immunocomplexes.[20]
Limitations1. Our study included smaller sample size. Future studies with large sample size may give better results.2. Our study did not include oral potentially malignant disorders (OPMD). Future studies with including OPMD may give better results as most of the OSCCs are preceded by OPMDs.
CONCLUSIONThe present study concludes that upregulation of MUC1 mucin expression in malignant lesions might play a vital role in the pathogenesis and its progression. It can also be a useful marker for prediction of the metastatic/invasive potential of OSCC. Hence, MUC1 mucin can be regarded as a valuable marker for OSCC. Future studies on comparative analysis of mutant types of MUC1 and its variable expression in invasive and non-invasive squamous cell carcinomas should be done.
Figure 1: (a) Photomicrograph of the section shows membrane 
and cytoplasmic staining in the epithelium and keratin pearl of well-
differentiated squamous cell carcinoma (IHC stain, ×40). (b) The 
corresponding H and E section, ×40
a b
Figure 2: (a) Photomicrograph of the section shows membranous 
and cytoplasmic staining in the epithelium of moderately differentiated 
squamous cell carcinoma (IHC stain, ×40). (b) The corresponding H 
and E section, ×40
a b
Figure 3: (a) Photomicrograph of the section shows membranous 
staining in the epithelium of poorly differentiated squamous cell 
carcinoma (IHC stain, ×40). (b) The corresponding H and E section, ×40
ba
www.apjhs.com Shobhita, et al.: MUC1 and oral squamous cell carcinoma
Asian Pacific Journal of Health Sciences  |  Vol. 5 | Issue 2 | April-June | 2018 Page | 169
REFERENCES
1. Akhter M, Hossain S, Rahman QB, Molla MR. A study on 
histological grading of oral squamous cell carcinoma and its 
co-relationship with regional metastasis. J Oral Maxillofac 
Pathol 2011;15:168-76.
2. Rachagani S, Torres MP, Moniaux N, Batra SK. Current status 
of mucins in the diagnosis and therapy of cancer. Biofactors 
2009;35:509-27.
3. Kumar MH, Sanjai K, Kumarswamy J, Keshavaiah R, 
Papaiah L, Divya S. Expression of MUC1 mucin in potentially 
malignant disorders, oral squamous cell carcinoma and 
normal oral mucosa: An immune histochemical study. J Oral 
Maxillofac Pathol 2016;20:214-8.
4. Li P, Xiao LY, Tan H. Muc-1 promotes migration and invasion 
of oral squamous cell carcinoma cells via PI3K-Akt signaling. 
Int J Clin Exp Pathol 2015;8:10365-74.
5. Fedchenko N, Reifenrath J. Different approaches for 
interpretation and reporting of immunohistochemistry 
analysis results in the bone tissue- A review. Diagn Pathol 
2014;9:221.
6. Mortazavi H, Baharvand M, Mehdipour M. Oral potentially 
malignant disorders: An overview of more than 20 entities. 
J Dent Res Dent Clin Dent Prospect 2014;8:6-14.
7. Singh MP, Kumar V, Agarwal A, Kumar R, Bhatt ML, 
Misra S. Clinico-epidemiological study of oral squamous cell 
carcinoma: A tertiary care centre study in North India. J Oral 
Biol Craniofac Res 2016;6:31-4.
8. Moulina T, Iskandarsyah A, Hardianto A, Sjamsudin E, 
Nandini M, Kasim A, et al. The incidence of oral squamous 
cell carcinoma (OSCC) and its relationship with orofacial pain 
in oral cancer patients in West Java Province, Indonesia. Oral 
Maxillofac Surg 2017;29:29-32.
9. Le Campion AC, Ribeiro CM, Luiz RR, Silva Júnior FF, 
Barros HC, Santos KC, et al. Low survival rates of oral 
and oropharyngeal squamous cell carcinoma. Int J Dent 
2017;7:S163.
10. Kaur S, Momi N, Charkraborty S, Wagner DG, Horn AJ, 
Lele SM, et al. Altered expression of transmembrane mucins, 
MUC1 and MUC4, in bladder cancer: Pathological Implications 
in Diagnosis. PloS One 2014;9:e92742.
11. Hollingsworth MA, Swanson BJ. Mucins in cancer: Protection 
and control of the cell surface. Nat Rev Cancer 2004;4:45-60.
12. Croce MV, Price MR, Segal-Eiras A. Detection and isolation 
of MUC1 mucin from larynx squamous cell carcinoma. Pathol 
Oncol Res 2000;6:93-9.
13. Nitta T, Sugihara K, Tsuyama S, Murata F. 
Immunohistochemical study of MUC1 mucin in premalignant 
oral lesions and oral squamous cell carcinoma: Association 
with disease progression, mode of invasion, and lymph node 
metastasis. Cancer 2000;88:245-54.
14. Hudson MJ, Stamp GW, Hollingsworth MA, Pignatelli M, 
Lalani EN. MUC1 expressed in PanC1 cells decreases 
adhesion to type1 collagen but increases contraction in 
collagen lattices. Am J Pathol 1996;148:951-60.
15. Schroeder JA, Adriance MC, Thompson MC, Camenisch TD, 
Gendler SJ. MUC1 alters beta-catenin-dependent tumor 
formation and promotes cellular invasion. Oncogene 
2003;22:1324-32.
16. Roy LD, Sahraei M, Subramani DB, Besmer D, Nath S, 
Tinder TL, et al. MUC1 enhances invasiveness of pancreatic 
cancer cells by inducing epithelial to mesenchymal transition. 
Oncogene 2011;30:1449-59.
17. Narashiman S, Narasimhan M, Venkatraman G. Expression 
of mucin 4 in leukoplakia and oral squamous cell carcinoma: 
An immunohistochemical study. J Oral Maxillofac Pathol 
2014;18:25-31.
18. Weed DT, Fernandez CG, Pacheco J, Ruiz J, Nelson KH, 
Arnold D, et al. Muc4 and Erbb2 expression in major and 
minor salivary gland mucoepidermoid carcinoma. Wiley Int 
Sci 2004;26:353-64.
19. Guillem P, Billeret V, Buisine MP, Flejou JF, Lecomte-
Houcke M, Degand P, et al. Mucin gene expression and cell 
differentiation in human normal, premalignant and malignant 
esophagus. Int J Cancer 2000;88:856-61.
20. Rabassa ME, Croce MV, Pereyra A, Segal-Eiras A. MUC1 
expression and anti-MUC1 serum immune response in head 
and neck squamous cell carcinoma (HNSCC): A multivariate 
analysis. BMC Cancer 2006;6:253.
How to cite this Article: Arguvanli SC, Mazicioğlu MM, Şafak ED, Göçer S, 
Akin S, Öztürk A. Prevalence of urinary incontinence and related risk factors 
in community-dwelling elderly. Asian Pac. J. Health Sci., 2018; 5(2):165-169.
Source of Support: Nil, Conflict of Interest: None declared.
